Calumet Specialty Prods Analyst Ratings
Calumet Specialty Prods Analyst Ratings
While ratings are subjective and will change, the latest Calumet Specialty Prods (CLMT) rating was a maintained with a price target of $19.00 to $17.00. The current price Calumet Specialty Prods (CLMT) is trading at is $14.01, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 21.34% | Goldman Sachs | $19 → $17 | Maintains | Buy |
| 08/07/2023 | 78.44% | HC Wainwright & Co. | → $25 | Reiterates | Buy → Buy |
| 06/13/2023 | 35.62% | Goldman Sachs | $20 → $19 | Maintains | Buy |
| 05/15/2023 | 39.19% | UBS | $18.5 → $19.5 | Maintains | Neutral |
| 05/08/2023 | 92.72% | Wells Fargo | $29 → $27 | Maintains | Overweight |
| 05/08/2023 | 64.17% | TD Cowen | $21 → $23 | Maintains | Outperform |
| 01/25/2023 | 78.44% | HC Wainwright & Co. | $28 → $25 | Maintains | Buy |
| 12/14/2022 | 12.06% | UBS | → $15.7 | Initiates Coverage On | → Neutral |
| 08/18/2022 | 64.17% | Goldman Sachs | $14 → $23 | Upgrades | Neutral → Buy |
| 06/28/2022 | 42.76% | Cowen & Co. | $18 → $20 | Maintains | Outperform |
| 05/09/2022 | 42.76% | Cowen & Co. | $18 → $20 | Maintains | Outperform |
| 04/21/2022 | 107% | Wells Fargo | $27 → $29 | Maintains | Overweight |
| 02/28/2022 | 99.86% | HC Wainwright & Co. | $19 → $28 | Maintains | Buy |
| 11/23/2021 | 114.13% | Wolfe Research | → $30 | Upgrades | Peer Perform → Outperform |
| 11/23/2021 | 64.17% | Cowen & Co. | $12 → $23 | Upgrades | Market Perform → Outperform |
| 10/15/2021 | -21.48% | Goldman Sachs | $6 → $11 | Maintains | Neutral |
| 10/08/2021 | -21.48% | Wells Fargo | $8 → $11 | Maintains | Overweight |
| 10/04/2021 | 35.62% | HC Wainwright & Co. | → $19 | Initiates Coverage On | → Buy |
| 03/24/2021 | -42.9% | Wells Fargo | → $8 | Upgrades | Equal-Weight → Overweight |
| 12/15/2020 | -71.45% | Wells Fargo | → $4 | Downgrades | Overweight → Equal-Weight |
| 03/27/2020 | -92.86% | Goldman Sachs | $2 → $1 | Maintains | Neutral |
| 02/11/2020 | — | Raymond James | Upgrades | Underperform → Market Perform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年10月31日 | 21.34% | 高盛 | $19→$17 | 维护 | 买 |
| 08/07/2023 | 78.44% | HC Wainwright公司 | →$25 | 重申 | 购买→购买 |
| 2023/06/13 | 35.62% | 高盛 | $20→$19 | 维护 | 买 |
| 2023年05月15日 | 39.19% | 瑞银集团 | $18.5→$19.5 | 维护 | 中性 |
| 05/08/2023 | 92.72% | 富国银行 | $29→$27 | 维护 | 超重 |
| 05/08/2023 | 64.17% | TD Cowen | $21→$23 | 维护 | 跑赢大盘 |
| 2023年1月25日 | 78.44% | HC Wainwright公司 | $28→$25 | 维护 | 买 |
| 2022年12月14日 | 12.06% | 瑞银集团 | →$15.7 | 开始承保 | →中性 |
| 2022/08/18 | 64.17% | 高盛 | $14→$23 | 升级 | 中性→购买 |
| 2022/06/28 | 42.76% | 考恩公司 | $18→$20 | 维护 | 跑赢大盘 |
| 05/09/2022 | 42.76% | 考恩公司 | $18→$20 | 维护 | 跑赢大盘 |
| 04/21/2022 | 107% | 富国银行 | $27→$29 | 维护 | 超重 |
| 02/28/2022 | 99.86% | HC Wainwright公司 | $19→$28 | 维护 | 买 |
| 2021年11月23日 | 114.13% | 沃尔夫研究 | →$30 | 升级 | 同业表现优于→ |
| 2021年11月23日 | 64.17% | 考恩公司 | $12→$23 | 升级 | 市场表现优于→ |
| 2021年10月15日 | -21.48% | 高盛 | $6→$11 | 维护 | 中性 |
| 10/08/2021 | -21.48% | 富国银行 | $8→$11 | 维护 | 超重 |
| 10/04/2021 | 35.62% | HC Wainwright公司 | →$19 | 开始承保 | →购买 |
| 03/24/2021 | -42.9% | 富国银行 | →$8 | 升级 | 等重→超重 |
| 12/15/2020 | -71.45% | 富国银行 | →$4 | 评级下调 | 超重→等重 |
| 03/27/2020 | -92.86% | 高盛 | $2→$1 | 维护 | 中性 |
| 02/11/2020 | - | 雷蒙德·詹姆斯 | 升级 | 表现逊于→市场表现 |
What is the target price for Calumet Specialty Prods (CLMT)?
Calumet特种产品(CLMT)的目标价格是多少？
The latest price target for Calumet Specialty Prods (NASDAQ: CLMT) was reported by Goldman Sachs on October 31, 2023. The analyst firm set a price target for $17.00 expecting CLMT to rise to within 12 months (a possible 21.34% upside). 8 analyst firms have reported ratings in the last year.
高盛于2023年10月31日报告了Calumet Specialty Prods(纳斯达克：CLMT)的最新目标价。这家分析公司将目标价定为17.00美元，预计CLMT将在12个月内上涨至21.34%。去年有8家分析公司公布了评级。
What is the most recent analyst rating for Calumet Specialty Prods (CLMT)?
Calumet Specialty Prods(CLMT)的最新分析师评级是什么？
The latest analyst rating for Calumet Specialty Prods (NASDAQ: CLMT) was provided by Goldman Sachs, and Calumet Specialty Prods maintained their buy rating.
纳斯达克的最新分析师评级由高盛提供，Calumet Specialty Prods维持买入评级。
When is the next analyst rating going to be posted or updated for Calumet Specialty Prods (CLMT)?
Calumet Specialty Prods(CLMT)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Calumet Specialty Prods, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Calumet Specialty Prods was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与Calumet Specialty Prods的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Calumet Specialty Prods的上一次评级是在2023年10月31日提交的，因此您应该预计下一次评级将在2024年10月31日左右提供。
Is the Analyst Rating Calumet Specialty Prods (CLMT) correct?
分析师评级Calumet Specialty Prods(CLMT)正确吗？
While ratings are subjective and will change, the latest Calumet Specialty Prods (CLMT) rating was a maintained with a price target of $19.00 to $17.00. The current price Calumet Specialty Prods (CLMT) is trading at is $14.01, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Calumet Specialty Prods(CLMT)评级保持不变，目标价在19.00美元至17.00美元之间。Calumet Specialty Prods(CLMT)目前的交易价格为14.01美元，超出了分析师的预测范围。
